Fenfluramine

  • Part D specialty tier in 79% of formularies (2026Q3)
  • Fintepla

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Fenfluramine: storage and handling

Freezing
Not addressed
Room temperature
at or below 30°C (86°F)
Label statement
Store FINTEPLA at room temperature between 20°C to 25°C (68°F to 77°F); excursions are permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
Room temperature
at or below 25°C (77°F)
Label statement
Store FINTEPLA at room temperature between 68°F to 77°F (20°C to 25°C).
Back into the refrigerator
Not addressed
Light
Not addressed
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (at up to 30°C (86°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

Store FINTEPLA at room temperature between 20°C to 25°C (68°F to 77°F); excursions are permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
Discard any unused portion 3 months after first opening the bottle or the "Discard After" date on the bottle, whichever is sooner.
Throw away (discard) any unused FINTEPLA 3 months after first opening the bottle or if the Discard After date on the package or bottle has passed.

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-844-288-5007 (the number printed on the label) about this product.

Where the label prints this number
A? The following items are included to prepare and give an oral dose of FINTEPLA: 1 bottle of FINTEPLA oral solution (2.2 mg/mL) 2 reusable oral syringes 1 Bottle of FINTEPLA Oral Solution (2.2 mg/mL) 2 Oral Syringes Call the pharmacist at 1-844-288-5007 if you did not receive the items listed above, or if you need help using them.
All storage statements on the label (7)
  • Store FINTEPLA at room temperature between 20°C to 25°C (68°F to 77°F); excursions are permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
  • Do not refrigerate or freeze.
  • Store the bottle and syringe together.
  • Discard any unused portion 3 months after first opening the bottle or the "Discard After" date on the bottle, whichever is sooner.
  • Store FINTEPLA at room temperature between 68°F to 77°F (20°C to 25°C).
  • Store the FINTEPLA bottle and syringe together in a clean area.
  • Throw away (discard) any unused FINTEPLA 3 months after first opening the bottle or if the Discard After date on the package or bottle has passed.

FDA label version 16, effective October 27, 2025. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

100%of plans list it
97%of those: prior authorization
0%step therapy
84%quantity limit
96%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.